TL;DR: Oracle Health has made its Clinical Note AI agent available to all UK customers after a pilot programme across NHS trusts including Barts Health, Imperial College Healthcare and Milton Keynes University Hospital. The tool uses ambient voice technology to draft patient notes, aiming to reduce administrative burden on clinicians.
From Pilot to Full UK Launch
The Clinical Note tool lets clinicians use ambient voice to draft patient notes during consultations, rather than typing them up afterwards. Oracle Health launched the AI agent in the US last year, and it is now used in more than 300 organisations globally.
Robin Kearney, consultant in acute medicine at Milton Keynes University Hospital, said the tool had “improved the accuracy of my notes and given me a lot of time back.” He described being able to focus entirely on patients during appointments and complete letters before they leave the department.
The participating NHS trusts — Barts Health, Imperial College Healthcare and Milton Keynes — are now expanding Clinical Note deployment across their organisations.
Part of a Broader NHS AI Push
Oracle Health holds 25% of the UK’s electronic patient record market among NHS acute trusts, according to a May 2025 report from Future Health Intelligence. The company has committed to investing $5bn (£3.7bn) in UK cloud services over the next five years.
The launch aligns with wider NHS adoption of ambient voice technology. In February, Alec Price-Forbes, NHS England’s national chief clinical information officer, described AVT as “an enabler for us truly to reimagine healthcare.” NHS England published a national self-certified registry for AVT suppliers in January, setting standards for clinical safety, technology and data protection.
Rival EPR provider Epic has also confirmed plans to integrate AI tools into its NHS offering.
Looking Forward
The expansion of clinical AI from pilot to production across NHS trusts is a concrete step beyond the experimentation phase. For UK health technology suppliers, the emerging AVT standards and supplier registry signal a maturing procurement framework — making it clearer what is required to sell AI tools into the NHS.